Pharmacokinetics of Eicosapentaenoic Acid in Plasma and Red Blood Cells After Multiple Oral Dosing With Icosapent Ethyl in Healthy Subjects.
about
Effect of concomitant icosapent ethyl (eicosapentaenoic acid ethyl ester) on the pharmacokinetics of atorvastatin.Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Pharmacokinetic Parameters of Rosiglitazone in Healthy Subjects.Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents.Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)Icosapent ethyl: a review of its use in severe hypertriglyceridemia.Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis.
P2860
Pharmacokinetics of Eicosapentaenoic Acid in Plasma and Red Blood Cells After Multiple Oral Dosing With Icosapent Ethyl in Healthy Subjects.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pharmacokinetics of Eicosapent ...... ent Ethyl in Healthy Subjects.
@ast
Pharmacokinetics of Eicosapent ...... ent Ethyl in Healthy Subjects.
@en
type
label
Pharmacokinetics of Eicosapent ...... ent Ethyl in Healthy Subjects.
@ast
Pharmacokinetics of Eicosapent ...... ent Ethyl in Healthy Subjects.
@en
prefLabel
Pharmacokinetics of Eicosapent ...... ent Ethyl in Healthy Subjects.
@ast
Pharmacokinetics of Eicosapent ...... ent Ethyl in Healthy Subjects.
@en
P2093
P2860
P356
P1476
Pharmacokinetics of Eicosapent ...... ent Ethyl in Healthy Subjects.
@en
P2093
Paresh N Soni
Rene A Braeckman
William G Stirtan
P2860
P304
P356
10.1002/CPDD.84
P577
2013-10-22T00:00:00Z